Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells

Background. Metabolic Syndrome (MetS), a major worldwide concern for the public health system, refers to a cluster of key metabolic components, and represents a risk factor for diabetes and cardiovascular diseases. As oxidative stress (OxS) and inflammation are the major triggers of insulin sensitiv...

Full description

Bibliographic Details
Main Authors: Mathilde Foisy-Sauvé, Lena Ahmarani, Edgard Delvin, Alain T. Sané, Schohraya Spahis, Emile Levy
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/12/4/1175
_version_ 1797569907140853760
author Mathilde Foisy-Sauvé
Lena Ahmarani
Edgard Delvin
Alain T. Sané
Schohraya Spahis
Emile Levy
author_facet Mathilde Foisy-Sauvé
Lena Ahmarani
Edgard Delvin
Alain T. Sané
Schohraya Spahis
Emile Levy
author_sort Mathilde Foisy-Sauvé
collection DOAJ
description Background. Metabolic Syndrome (MetS), a major worldwide concern for the public health system, refers to a cluster of key metabolic components, and represents a risk factor for diabetes and cardiovascular diseases. As oxidative stress (OxS) and inflammation are the major triggers of insulin sensitivity (IS), a cardinal MetS feature, the principal aim of the present work is to determine whether glycomacropeptide (GMP), a milk-derived bioactive peptide, exerts beneficial effects on their expression. Methods. Fully differentiated intestinal Caco-2/15 cells are used to evaluate the preventive action of 2 mg/mL GMP against OxS and inflammation induced by the mixture iron-ascorbate (Fe/Asc) (200 μM:2 mM). The potency of GMP of decreasing the production of lipoproteins, including chylomicrons (CM), very-low-density lipoproteins (VLDL) and low-density lipoproteins (LDL) is also assessed. Results. The administration of GMP significantly reduces malondialdehyde, a biomarker of lipid peroxidation, and raises superoxide dismutase 2 and glutathione peroxidase via the induction of the nuclear factor erythroid 2–related factor 2, a transcription factor, which orchestrates cellular antioxidant defenses. Similarly, GMP markedly lowers the inflammatory agents tumor necrosis factor-α and cyclooxygenase-2 via abrogation of the nuclear transcription factor-kB. Moreover, GMP-treated cells show a down-regulation of Fe/Asc-induced mitogen activated protein kinase pathway, suggesting greater IS. Finally, GMP decreases the production of CM, VLDL, and LDL. Conclusions. Our results highlight the effectiveness of GMP in attenuating OxS, inflammation and lipoprotein biogenesis, as well as improving IS, the key components of MetS. Further investigation is needed to elucidate the mechanisms mediating the preventive action of GMP.
first_indexed 2024-03-10T20:17:56Z
format Article
id doaj.art-fd17b2b480fa446da9186dc2b108c341
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-10T20:17:56Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-fd17b2b480fa446da9186dc2b108c3412023-11-19T22:25:57ZengMDPI AGNutrients2072-66432020-04-01124117510.3390/nu12041175Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 CellsMathilde Foisy-Sauvé0Lena Ahmarani1Edgard Delvin2Alain T. Sané3Schohraya Spahis4Emile Levy5Research Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaResearch Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaResearch Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaResearch Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaResearch Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaResearch Centre, CHU Ste-Justine, Montreal, QC H3T 1C5, CanadaBackground. Metabolic Syndrome (MetS), a major worldwide concern for the public health system, refers to a cluster of key metabolic components, and represents a risk factor for diabetes and cardiovascular diseases. As oxidative stress (OxS) and inflammation are the major triggers of insulin sensitivity (IS), a cardinal MetS feature, the principal aim of the present work is to determine whether glycomacropeptide (GMP), a milk-derived bioactive peptide, exerts beneficial effects on their expression. Methods. Fully differentiated intestinal Caco-2/15 cells are used to evaluate the preventive action of 2 mg/mL GMP against OxS and inflammation induced by the mixture iron-ascorbate (Fe/Asc) (200 μM:2 mM). The potency of GMP of decreasing the production of lipoproteins, including chylomicrons (CM), very-low-density lipoproteins (VLDL) and low-density lipoproteins (LDL) is also assessed. Results. The administration of GMP significantly reduces malondialdehyde, a biomarker of lipid peroxidation, and raises superoxide dismutase 2 and glutathione peroxidase via the induction of the nuclear factor erythroid 2–related factor 2, a transcription factor, which orchestrates cellular antioxidant defenses. Similarly, GMP markedly lowers the inflammatory agents tumor necrosis factor-α and cyclooxygenase-2 via abrogation of the nuclear transcription factor-kB. Moreover, GMP-treated cells show a down-regulation of Fe/Asc-induced mitogen activated protein kinase pathway, suggesting greater IS. Finally, GMP decreases the production of CM, VLDL, and LDL. Conclusions. Our results highlight the effectiveness of GMP in attenuating OxS, inflammation and lipoprotein biogenesis, as well as improving IS, the key components of MetS. Further investigation is needed to elucidate the mechanisms mediating the preventive action of GMP.https://www.mdpi.com/2072-6643/12/4/1175glycomacropeptideoxidative stressinflammationinsulin sensitivitymetabolic syndromemilk-derived bioactive peptide
spellingShingle Mathilde Foisy-Sauvé
Lena Ahmarani
Edgard Delvin
Alain T. Sané
Schohraya Spahis
Emile Levy
Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
Nutrients
glycomacropeptide
oxidative stress
inflammation
insulin sensitivity
metabolic syndrome
milk-derived bioactive peptide
title Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
title_full Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
title_fullStr Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
title_full_unstemmed Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
title_short Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells
title_sort glycomacropeptide prevents iron ascorbate induced oxidative stress inflammation and insulin sensitivity with an impact on lipoprotein production in intestinal caco 2 15 cells
topic glycomacropeptide
oxidative stress
inflammation
insulin sensitivity
metabolic syndrome
milk-derived bioactive peptide
url https://www.mdpi.com/2072-6643/12/4/1175
work_keys_str_mv AT mathildefoisysauve glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells
AT lenaahmarani glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells
AT edgarddelvin glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells
AT alaintsane glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells
AT schohrayaspahis glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells
AT emilelevy glycomacropeptidepreventsironascorbateinducedoxidativestressinflammationandinsulinsensitivitywithanimpactonlipoproteinproductioninintestinalcaco215cells